SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: betty moyers who wrote (12887)8/10/1998 7:26:00 AM
From: DaiS  Read Replies (2) of 23519
 
Betty or anyone,

Can you help me with technical question regarding Vivus counting product shipped as product sold. To say that it is fortunate that Vivus can do this is an understatement as it appears that UK will be only big market open before the end of the quarter. Sales to consumers will never soak up the >5 million units produced this quarter.

Is this a book-keeping exercise, or will Vivus actually receive from Astra and Janssen the money up front? If Vivus don't get the money then their cash position would surely be very badly affected, particularly with viagra coming online to affect UK sales and the delays in country approvals.

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext